Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H889A for postoperative pain after bunion/hallux valgus corrective surgery
CTR20263193Phase 3Active
- Sponsor
- Huizhong Jishi Biotechnology
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of H889A in postoperative pain, sponsored by Huizhong Jishi Biotechnology. Started Aug 2026; status: active.
02
Drugs
H889A
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20263193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263193.